Moderate to Severe Atopic Dermatitis
Fed up with painful eczema or atopic dermatitis flare ups? Your eczema or atopic dermatitis just won't quit. But neither will you. See if you may be eligible to participate.
Study site: Encore Medical Research
- Eczema (atopic dermatitis)
- About the Study
- Atopic dermatitis, a form of eczema, is a chronic condition that causes the skin to become inflamed, irritated, and itchy. This study explores the effectiveness and continued safety of an investigational medication versus placebo in adults with moderate to severe atopic dermatitis. Approximately 105 participants will be enrolled.
- What does the study involve?
- The study will involve at least 18 total visits to the study center, which take place over the course of around 10 months (43 weeks). The investigational medication is delivered through injection under the skin (subcutaneous).
- Who can participate?
- You may be able to take part in this study if you are at least 18 years old, have had an Atopic Dermatitis diagnosis for at least 1 year, and have been unsuccessful treating your Atopic Dermatitis with topical treatments or phototherapy.
- Is compensation provided?
- Yes: Up to $5400 for taking part.
Where is the study taking place?
Hollywood
Weston
Boynton Beach
Study details
Full record on ClinicalTrials.gov (NCT05048056)Study details are from ClinicalTrials.gov. The rest of this page is written by the study site for patients and may summarize or reword the registry record, which is the official text. A study listed on ClinicalTrials.gov has not necessarily been reviewed or approved by the U.S. government.
About Encore Medical Research
Encore Medical Research has been serving the South Florida Community since 2017 focusing on phases II through IV clinical trials. Our goal is to provide the highest standard of care to our patients while delivering unmatched performance in our research operations.